Macrogen Inc Market Cap ($74.70 Million)
Market Cap & Net Worth: Macrogen Inc (038290)
Macrogen Inc market cap. Macrogen Inc (KQ:038290) has a market capitalization of $74.70 Million (₩110.23 Billion) as of November 3, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #20179 globally and #1080 in its home market, demonstrating a -1.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Macrogen Inc's stock price ₩11000.00 by its total outstanding shares 10021300 (10.02 Million). Also see Macrogen Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Macrogen Inc Market Cap History (2015–2026)
Macrogen Inc market cap history from 2015 to 2026. Data shows change from $223.64 Million to $74.70 Million (-10.16% CAGR). Check Macrogen Inc (038290) stock price for real-time trading data and today's change.
Index Memberships
Macrogen Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$211.91 Billion | 0.04% | #465 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$211.91 Billion | 0.04% | #465 of 1384 |
Weight: Macrogen Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Macrogen Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Macrogen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 038290 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Macrogen Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $223.64 Million | $79.53 Billion | $10.17 Billion | 0.00x | 0.02x |
| 2016 | $212.04 Million | $91.11 Billion | $4.30 Billion | 0.00x | 0.05x |
| 2017 | $233.95 Million | $101.79 Billion | $9.53 Billion | 0.00x | 0.02x |
| 2018 | $188.83 Million | $112.83 Billion | $2.65 Billion | 0.00x | 0.07x |
| 2019 | $159.83 Million | $122.25 Billion | -$3.50 Billion | 0.00x | N/A |
| 2020 | $176.71 Million | $112.60 Billion | $88.34 Billion | 0.00x | 0.00x |
| 2021 | $194.37 Million | $129.17 Billion | $1.11 Billion | 0.00x | 0.17x |
| 2022 | $128.19 Million | $138.62 Billion | -$22.25 Billion | 0.00x | N/A |
| 2023 | $142.62 Million | $132.80 Billion | -$16.81 Billion | 0.00x | N/A |
| 2024 | $111.92 Million | $135.78 Billion | -$7.60 Billion | 0.00x | N/A |
Competitor Companies of 038290 by Market Capitalization
Companies near Macrogen Inc in the global market cap rankings as of November 3, 2026. Also see 038290 total asset value for a full breakdown of the balance sheet.
Key companies related to Macrogen Inc by market ranking:
- Peptron Inc (KQ:087010): Ranked #8669 globally with a market cap of $984.64 Million USD ( ₩1.45 Trillion KRW).
- Bioneer Corporation (KQ:064550): Ranked #18917 globally with a market cap of $102.73 Million USD ( ₩151.59 Billion KRW).
- Pluristem (TA:PSTI): Ranked #23207 globally with a market cap of $33.40 Million USD ( ILA12.46 Billion ILA).
- Panagene Inc (KQ:046210): Ranked #23685 globally with a market cap of $29.21 Million USD ( ₩43.10 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #8669 | Peptron Inc | KQ:087010 | $984.64 Million | ₩94800.00 |
| #18917 | Bioneer Corporation | KQ:064550 | $102.73 Million | ₩6860.00 |
| #23207 | Pluristem | TA:PSTI | $33.40 Million | ILA385.10 |
| #23685 | Panagene Inc | KQ:046210 | $29.21 Million | ₩1341.00 |
Market Capitalization of Macrogen Inc (2015–2026)
Market capitalization of Macrogen Inc from 2015 to today. Between 2015 and today, Macrogen Inc's market cap moved from $223.64 Million to $ 74.70 Million, with a yearly change of -10.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩74.70 Million | -34.80% |
| 2025 | ₩114.57 Million | +2.37% |
| 2024 | ₩111.92 Million | -21.52% |
| 2023 | ₩142.62 Million | +11.26% |
| 2022 | ₩128.19 Million | -34.05% |
| 2021 | ₩194.37 Million | +10.00% |
| 2020 | ₩176.71 Million | +10.56% |
| 2019 | ₩159.83 Million | -15.36% |
| 2018 | ₩188.83 Million | -19.28% |
| 2017 | ₩233.95 Million | +10.33% |
| 2016 | ₩212.04 Million | -5.19% |
| 2015 | ₩223.64 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Macrogen Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $74.70 Million USD |
| MoneyControl | $74.70 Million USD |
| MarketWatch | $74.70 Million USD |
| marketcap.company | $74.70 Million USD |
| Reuters | $74.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Macrogen Inc
Macrogen, Inc. provides genetic and genomic analysis research services in South Korea and internationally. It offers next generation sequencing (NGS) services, such as whole genome, exome, targeted, transcriptome, metagenome, epigenome, and single cell multi-omics sequencing, as well as whole genome resequencing; and standard, difficult template, and 16S/18S/26S rRNA and ITS region sequencing ser… Read more